Sale!
TREXIMET Drug Profile, 2024

TREXIMET Drug Profile, 2024

Original price was: $800.00.Current price is: $399.00.

TREXIMET (naproxen sodium; sumatriptan succinate) drug patents, PTAB cases, SPCs, clinical trials, suppliers

SKU: TREXIMET Category:
Originally published at https://www.chemintel360.com/. Get our excipient business reports at https://chemintel360.com/product-category/excipients/, and our drug patent reports at https://chemintel360.com/product-category/drug-patent-reports/

TREXIMET Drug Profile, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs.

This definitive guide provides invaluable business insights into every crucial aspect of this medication, addressing the vital points necessary to make business decisions.

Gain key critical insights for TREXIMET:

  • United States patents
  • Expired United States patents
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Finished product suppliers
Pages

63
Product

TREXIMET

Related products

ChemIntel360
Scroll to Top